Trade Vir Biotechnology VIR

Magbenta
 Bumili

VirBiotechnology live chart

5m 15m 30m 1h 4h 1d 1w

Mga Pangunahing Kaalaman sa Instrumento

Weekly Search
Weekly
Daily
Petsa Isarado Pagbabago Change (%) Buksan High Low

VirBiotechnology news

Mga pinakabagong balita

Ipakita nang marami
Liam James 2025 Jul 18, 04:20

Trump Administration to Release Epstein Grand Jury Testimony Amid Mounting Pressure

Emma Rose 2025 Jul 18, 03:20

OpenAI Enters AI Agent Race with ChatGPT Agent Launch

Liam James 2025 Jul 18, 01:20

Warsh Calls for Fed Reform and Policy Alignment with Treasury

Sophia Claire 2025 Jul 18, 01:20

US House Passes Stablecoin and Crypto Regulatory Bills

Ghko B 2025 Jul 17, 16:00

Stock Market Today: Dow Rises 250 Points, S&P 500, Nasdaq Futures Steady

Stocks
Ava Grace 2025 Jul 17, 13:20

US Consumer Spending Defies Tariff Impact: Resilience or Price Inflation?

Ava Grace 2025 Jul 17, 10:21

Gold Price Forecast 2025-2026: A Comprehensive Analysis by the World Gold Council

Sophia Claire 2025 Jul 17, 10:20

EU Prepares Retaliatory Measures Against US Amid Trade Dispute

Info

Spread

0.05

Spread (%)

0.9158 %

Leverage

1:10

Interes sa Magdamagang Pagbili

-0.0597 %

Interes sa Magdamagang Pagtinda

-0.0292 %

Currency

USD

Trading Hours

Oras ng Pagsasara

Biyernes

13:31 - 19:59

Lunes

13:31-19:59

Martes

13:31-19:59

Miyerkules

13:31-19:59

Huwebes

13:31-19:59

Analys och statistik

Buksan

---

Nakaraang Pagsara

---

52 Linggo Mataas/Mababa

--- – ---

Market Cap

747867584

Natitirang Pagbabahagi

138238000

Petsa ng Mga Kita (Susunod)

0000-00-00

Pambayad si dividend

Araw ng Pag-alis ng Karapatan sa Dividend

Inaasahang Taunang Rate ng Dividend

0

Inaasahang Taunang Dividend Yield

0

EPS

-4.23

Alamin ang Higit Pa Tungkol sa Instrumentong ito

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Mga kaugnay na instrumento

Asset
Magbenta
Bumili
Change (%)

Mag-trade Ngayon

Mag-trade Ngayon

Mag-trade Ngayon

Mag-trade Ngayon
view_all_instruments

latest_education_articles

Ipakita nang marami
Trustpilot